Genient Technologies was pleased to participate in VIROGLOBAL 2026, the Manipal Institute of Virology (MIV), MAHE – ICMR-National Institute of Virology (ICMR-NIV) Joint International Conference on Virology.
Hosted by the Manipal Institute of Virology (MIV), MAHE in association with the ICMR-National Institute of Virology (ICMR-NIV), the conference was centered on the theme, “Frontiers in Virology: Bridging Discovery, Technology & Public Health.”
VIROGLOBAL 2026 served as an important scientific platform for dialogue and collaboration across the virology community, bringing together researchers, clinicians, public health leaders, and laboratory experts from around the world.
As infectious diseases continue to evolve and impact global health systems, the role of virology has become increasingly critical in surveillance, outbreak preparedness, diagnostics, and public health response.
VIROGLOBAL 2026 provided an exceptional platform for scientific exchange, featuring discussions across a broad range of disciplines that are shaping the future of virology and infectious disease management.
During the conference, Genient Technologies engaged with participants from across the scientific and clinical ecosystem and contributed to conversations surrounding advanced genomics, molecular diagnostics, and innovation in pathogen detection.
Discussions highlighted the growing importance of precision technologies in supporting faster detection, deeper pathogen characterization, and improved public health decision-making.
The interactions reinforced the value of collaboration between researchers, clinicians, public health professionals, and diagnostic innovators in addressing evolving infectious disease challenges.
Held on 16–17 April 2026 at Fortune Inn Valley View, Manipal, VIROGLOBAL 2026 provided a valuable forum for scientific exchange and shared perspectives on the evolving future of virology and public health.
Genient Technologies was honored to be part of this important gathering and appreciated the opportunity to connect with the broader virology community while supporting discussions that advance innovation in diagnostics and infectious disease research.
As genomics and molecular technologies continue to transform pathogen detection and disease surveillance, Genient Technologies remains committed to supporting laboratories, researchers, and healthcare professionals with innovative solutions that drive scientific progress and improve healthcare outcomes.
Advancing Virology Through Science, Innovation, and Collaboration.